127 related articles for article (PubMed ID: 2849960)
1. Construction of a chimaeric type 1/type 2 poliovirus by genetic recombination.
Martin A; Wychowski C; Benichou D; Crainic R; Girard M
Ann Inst Pasteur Virol; 1988; 139(1):79-88. PubMed ID: 2849960
[TBL] [Abstract][Full Text] [Related]
2. The use of a monoclonal antibody and of DNA recombinant technology for the localization of a poliovirus neutralization epitope in viral capsid polypeptide VP1.
Bruneau P; van der Werf S; Wychowski C; Siffert O; Girard M
Dev Biol Stand; 1984; 57():177-85. PubMed ID: 6084609
[TBL] [Abstract][Full Text] [Related]
3. Analysis of neutralization-escape mutants selected from a mouse virulent type 1/type 2 chimeric poliovirus: identification of a type 1 poliovirus with antigenic site 1 deleted.
Couderc T; Martin A; Wychowski C; Girard M; Horaud F; Crainic R
J Gen Virol; 1991 Apr; 72 ( Pt 4)():973-7. PubMed ID: 1707949
[TBL] [Abstract][Full Text] [Related]
4. Mapping of sequences required for mouse neurovirulence of poliovirus type 2 Lansing.
La Monica N; Meriam C; Racaniello VR
J Virol; 1986 Feb; 57(2):515-25. PubMed ID: 3003384
[TBL] [Abstract][Full Text] [Related]
5. A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain.
Kohara M; Abe S; Komatsu T; Tago K; Arita M; Nomoto A
J Virol; 1988 Aug; 62(8):2828-35. PubMed ID: 2839704
[TBL] [Abstract][Full Text] [Related]
6. N-AgIB of poliovirus type 1: a discontinuous epitope formed by two loops of VP1 comprising residues 96-104 and 141-152.
Wiegers K; Uhlig H; Dernick R
Virology; 1989 Jun; 170(2):583-6. PubMed ID: 2471354
[TBL] [Abstract][Full Text] [Related]
7. Poliovirus host range is determined by a short amino acid sequence in neutralization antigenic site I.
Murray MG; Bradley J; Yang XF; Wimmer E; Moss EG; Racaniello VR
Science; 1988 Jul; 241(4862):213-5. PubMed ID: 2838906
[TBL] [Abstract][Full Text] [Related]
8. Engineering a poliovirus type 2 antigenic site on a type 1 capsid results in a chimaeric virus which is neurovirulent for mice.
Martin A; Wychowski C; Couderc T; Crainic R; Hogle J; Girard M
EMBO J; 1988 Sep; 7(9):2839-47. PubMed ID: 2460345
[TBL] [Abstract][Full Text] [Related]
9. Expression of a poliovirus neutralization epitope at the surface of recombinant bacteria: first immunization results.
Charbit A; Van der Werf S; Mimic V; Boulain JC; Girard M; Hofnung M
Ann Inst Pasteur Microbiol; 1988; 139(1):45-58. PubMed ID: 2454645
[TBL] [Abstract][Full Text] [Related]
10. Mutations conferring resistance to neutralization with monoclonal antibodies in type 1 poliovirus can be located outside or inside the antibody-binding site.
Blondel B; Crainic R; Fichot O; Dufraisse G; Candrea A; Diamond D; Girard M; Horaud F
J Virol; 1986 Jan; 57(1):81-90. PubMed ID: 2416957
[TBL] [Abstract][Full Text] [Related]
11. Construction and characterization of a poliovirus/rhinovirus antigenic hybrid.
Altmeyer R; Murdin AD; Harber JJ; Wimmer E
Virology; 1991 Oct; 184(2):636-44. PubMed ID: 1653493
[TBL] [Abstract][Full Text] [Related]
12. Critical role of neighbouring sequences on the immunogenicity of the C3 poliovirus neutralization epitope expressed at the surface of recombinant bacteria.
van der Werf S; Charbit A; Leclerc C; Mimic V; Ronco J; Girard M; Hofnung M
Vaccine; 1990 Jun; 8(3):269-77. PubMed ID: 1694613
[TBL] [Abstract][Full Text] [Related]
13. Antigenic structure of polioviruses of serotypes 1, 2 and 3.
Minor PD; Ferguson M; Evans DM; Almond JW; Icenogle JP
J Gen Virol; 1986 Jul; 67 ( Pt 7)():1283-91. PubMed ID: 2425046
[TBL] [Abstract][Full Text] [Related]
14. Identification of a T-cell epitope adjacent to neutralization antigenic site 1 of poliovirus type 1.
Leclerc C; Deriaud E; Mimic V; van der Werf S
J Virol; 1991 Feb; 65(2):711-8. PubMed ID: 1702841
[TBL] [Abstract][Full Text] [Related]
15. Mapping of type 1 poliovirus neutralization epitopes.
Blondel B; Crainic R; Dufraisse G; Candréa A; Horaud F
Dev Biol Stand; 1985; 60():337-42. PubMed ID: 2412917
[TBL] [Abstract][Full Text] [Related]
16. Localization of a poliovirus type 1 neutralization epitope in viral capsid polypeptide VP1.
van der Werf S; Wychowski C; Bruneau P; Blondel B; Crainic R; Horodniceanu F; Girard M
Proc Natl Acad Sci U S A; 1983 Aug; 80(16):5080-4. PubMed ID: 6308670
[TBL] [Abstract][Full Text] [Related]
17. A poliovirus type 1 neutralization epitope is located within amino acid residues 93 to 104 of viral capsid polypeptide VP1.
Wychowski C; van der Werf S; Siffert O; Crainic R; Bruneau P; Girard M
EMBO J; 1983; 2(11):2019-24. PubMed ID: 6196195
[TBL] [Abstract][Full Text] [Related]
18. Evolution of poliovirus during an outbreak: sequential type 3 poliovirus isolates from several persons show shifts of neutralization determinants.
Huovilainen A; Hovi T; Kinnunen L; Takkinen K; Ferguson M; Minor P
J Gen Virol; 1987 May; 68 ( Pt 5)():1373-8. PubMed ID: 2437244
[TBL] [Abstract][Full Text] [Related]
19. Principal and subsidiary antigenic sites of VP1 involved in the neutralization of poliovirus type 3.
Minor PD; Evans DM; Ferguson M; Schild GC; Westrop G; Almond JW
J Gen Virol; 1985 May; 66 ( Pt 5)():1159-65. PubMed ID: 2582084
[TBL] [Abstract][Full Text] [Related]
20. Location and primary structure of a major antigenic site for poliovirus neutralization.
Minor PD; Schild GC; Bootman J; Evans DM; Ferguson M; Reeve P; Spitz M; Stanway G; Cann AJ; Hauptmann R; Clarke LD; Mountford RC; Almond JW
Nature; 1983 Feb; 301(5902):674-9. PubMed ID: 6186919
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]